Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.36 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4432594 | 1.00 | FFAR1 (0.44) | FFAR1FFAR4FAAHPPARGGPR132 | |
| SCHEMBL30774404 | 0.98 | FFAR1 (0.46) | FFAR1FFAR4FAAHPPARGGPR132 | |
| 3-Octanol SCHEMBL29083521 | 0.94 | FFAR1 (0.51) | FFAR1FFAR4FAAHPPARGGPR132 | |
| SCHEMBL14144643 | 0.93 | FFAR1 (0.38) | FFAR1FFAR4FAAHPPARGGPR132 | |
| SCHEMBL5214456 | 0.84 | — | — | |
| SCHEMBL5214461 | 0.84 | — | — | |
| SCHEMBL6756697 | 0.83 | FFAR1 (0.57) | FFAR1FFAR4FAAHPPARGGPR132 | |
| SCHEMBL17179814 | 0.83 | FFAR1 (0.57) | FFAR1FFAR4FAAHPPARGGPR132 | |
| SCHEMBL19371487 | 0.83 | FFAR1 (0.49) | FFAR1FFAR4FAAHPPARGGPR132 | |
| SCHEMBL28843025 | 0.83 | ALDH1A1 (0.41) | FFAR1FFAR4FAAHPPARGGPR132 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116348463-A | Spiro derivatives of alpha-D-galactopyranoside | 爱杜西亚药品有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116348463-A | Spiro derivatives of alpha-D-galactopyranoside | 爱杜西亚药品有限公司 | 2023-06-27 | — | — | CN | disclosed |
| EP-4103576-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | Glycoscience, S.L. (ES) | 2022-12-21 | — | — | EP | disclosed |
| WO-2021160670-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GLYCOSCIENCE, S.L. (ES) | 2021-08-19 | — | — | WO | disclosed |
| EP-2124944-A1 | PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | Ranbaxy Laboratories Limited (IN) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008111010-A1 | PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2008-09-18 | — | — | WO | disclosed |
| EP-1948167-A1 | COMPOSITIONS OF PHOSPHODIESTERASE TYPE IV INHIBITORS | RANBAXY LABORATORIES, LTD. (IN) | 2008-07-30 | — | — | EP | disclosed |
| EP-1869054-A2 | CONDENSED ISOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | Ranbaxy Laboratories Limited (IN) | 2007-12-26 | — | — | EP | disclosed |
| WO-2007045980-A1 | COMPOSITIONS OF PHOSPHODIESTERASE TYPE IV INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2007-04-26 | — | — | WO | disclosed |
| WO-2006085212-A2 | CONDENSED ISOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE TYPE-IV | RANBAXY LABORATORIES LIMITED (IN) | 2006-08-17 | — | — | WO | disclosed |